News
Equitable (EQH) Q2 EPS Drops 23%
Equitable (NYSE:EQH), a diversified provider of insurance, retirement, asset management, and financial planning services, reported its Q2 2025 earnings on August 5, 2025. The headline news from the
Adtran (ADTN) Q2 Revenue Jumps 17%
Adtran (NASDAQ:ADTN), a provider of fiber networking equipment and solutions for communications networks, released its second quarter 2025 results on August 5, 2025. The company delivered revenue
Voya (VOYA) Q2 EPS Jumps 20%
Voya Financial (NYSE:VOYA), a leading provider of retirement, investment, and employee benefit solutions, reported its Q2 2025 earnings on August 5, 2025. The standout result was non-GAAP earnings
Astera Labs (ALAB) Q2 Revenue Soars 150%
Astera Labs (NASDAQ:ALAB), a provider of connectivity solutions for cloud and artificial intelligence (AI) infrastructure, released its results for Q2 FY2025 on August 5, 2025. The report delivered
Sensei (SNSE) Q2 Loss Narrows 31%
Sensei Biotherapeutics (NASDAQ:SNSE) is a clinical-stage immunotherapy company developing innovative antibody treatments for cancer. On August 5, 2025, it reported financial results for the second
LifeMD (LFMD) Q2 Revenue Rises 23%
LifeMD (NASDAQ:LFMD), a telehealth platform specializing in virtual care and digital health subscriptions, reported its second quarter 2025 financial results on August 5, 2025. Revenue (GAAP) was
Xometry (XMTR) Q2 Revenue Jumps 23%
Xometry (NASDAQ:XMTR), the online marketplace for on-demand manufacturing, reported its second-quarter 2025 earnings on August 5, 2025. GAAP revenue was $162.5 million in Q2 2025, ahead of the
Revolve (RVLV) Q2 Revenue Up 9%
Revolve Group (NYSE:RVLV), an online fashion retailer known for its youth-driven strategy and influencer partnerships, released its second quarter fiscal 2025 results on August 5, 2025. GAAP revenue
Ranpak (PACK) Q2 Revenue Rises 7%
Ranpak (NYSE:PACK), a global supplier of environmentally sustainable packaging solutions, released its second-quarter 2025 earnings on August 5, 2025. The most important news was that it posted net
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats
QuidelOrtho (NASDAQ:QDEL), a global provider of diagnostic testing solutions, released its financial results for the quarter ended June 29, 2025, on August 5, 2025. The most notable headline was a
Flotek (FTK) Q2 Revenue Jumps 26%
Flotek Industries (NYSE:FTK), a developer of specialty chemistry products and advanced data analytics for the energy sector, reported second quarter 2025 earnings on August 5, 2025. The company
Shoals (SHLS) Q2 Revenue Jumps 12%
Shoals Technologies Group (NASDAQ:SHLS), a leading provider of electrical balance of system (EBOS) solutions for solar and energy storage projects, posted its second quarter 2025 results on August
TransDigm (TDG) Q3 Margin Hits 54%
TransDigm Group (NYSE:TDG), a leading supplier of proprietary aerospace components, reported earnings for Q3 FY2025 on August 5, 2025. Headline results showed revenue of $2,237 million and non-GAAP
Esperion (ESPR) Q2 Revenue Jumps 12%
Esperion Therapeutics (NASDAQ:ESPR), a specialty pharmaceutical company focused on cardiovascular disease, delivered higher-than-expected GAAP results in its latest earnings release. On August 5
IBRX Sales Soar 2,540%
ImmunityBio (NASDAQ:IBRX), a commercial-stage biotechnology company, released its second-quarter results on August 5, 2025. The main headline: revenue (GAAP) jumped to $26.4 million, soundly beating
Sealed Air (SEE) Q2 EPS Jumps 7%
Sealed Air (NYSE:SEE), the global packaging company behind widely recognized brands such as BUBBLE WRAP and CRYOVAC, released its second quarter 2025 results on August 5, 2025. The headline news is
Enpro (NPO) Q2 Revenue Rises 6%
Enpro (NYSE:NPO), a specialized manufacturer serving critical markets like semiconductors, aerospace, and life sciences, reported its second quarter 2025 earnings on August 5, 2025. Revenue (GAAP)
Contineum (CTNM) Q2 R&D Jumps 78%
Contineum Therapeutics (NASDAQ:CTNM), a clinical-stage biotechnology company focused on developing treatments for serious diseases such as pulmonary fibrosis, multiple sclerosis, and depression
EQS-News: Q2 2025: ElringKlinger records improved operating profit amid challenging conditions
EQS-News: Nordex Group receives order for nearly 52 MW from TEUT Energieprojekte in Germany
EQS-News: voestalpine AG: voestalpine holds its ground in a challenging economic environment and generates strong free cash flow in Q1 2025/26
EQS-News: ZEAL continues its path of success in the first half of 2025 and records growth in customer base and profitability
OrthoPediatrics (KIDS) Q2 Revenue Up 16%
OrthoPediatrics (NASDAQ:KIDS), a specialist in pediatric orthopedic medical devices, reported its financial results for the second quarter on August 5, 2025. OrthoPediatrics reported GAAP revenue of
EQS-News: Vonovia reports 11% growth in earnings and raises EBT guidance for 2025 by €100 million



